Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 297 | 274 | 67 | 237 | 380 |
| Cost of Goods | 287 | 301 | 336 | 206 | 133 |
| Gross Profit | 10 | -27 | -269 | 31 | 247 |
| Operating Expenses | -5,553 | 11,922 | 1,773 | 1,863 | 3,397 |
| Operating Income | 5,850 | -11,648 | -1,706 | -1,626 | -3,017 |
| Interest Expense | 11 | 18 | 14 | 21 | 30 |
| Other Income | 120 | -351 | -98 | 283 | -366 |
| Pre-tax Income | 5,959 | -12,017 | -1,818 | -1,364 | -3,413 |
| Net Income Continuous | 5,959 | -12,017 | -1,818 | -1,364 | -3,413 |
| Net Income Discontinuous | -2,926 | -32,961 | -7,515 | -6,936 | -6,878 |
| Net Income | $3,033 | $-44,978 | $-9,333 | $-8,300 | $-10,291 |
| EPS Basic Total Ops | 0.40 | -7.95 | -1.62 | -1.48 | -2.20 |
| EPS Basic Continuous Ops | 0.82 | -2.10 | -0.31 | -0.24 | -0.80 |
| EPS Basic Discontinuous Ops | -0.42 | -5.90 | -1.27 | -1.23 | -1.40 |
| EPS Diluted Total Ops | 0.40 | -7.95 | -1.62 | -1.48 | -2.20 |
| EPS Diluted Continuous Ops | 0.82 | -2.10 | -0.31 | -0.24 | -0.80 |
| EPS Diluted Discontinuous Ops | -0.42 | -5.90 | -1.27 | -1.23 | -1.40 |
| EBITDA(a) | $6,322 | $8,314 | $-338 | $-262 | $-1,795 |